| Net loss | -56.12M |
| Income from discontinued operations, net of tax | 1.34M |
| Net loss from continuing operations | -57.46M |
| Impairment loss | 34.28M |
| Depreciation and amortization | 1.89M |
| Amortization of debt discount and deferred financing fees | 4.19M |
| Share-based compensation | 1.03M |
| Gain on debt extinguishment | 0 |
| Net (gain) loss on disposal of property, plant and equipment | 0 |
| Equity loss | 118K |
| Accounts receivable | 12.58M |
| Inventories | -2.01M |
| Other assets | 11.93M |
| Accounts payable and accrued expenses | -15.4M |
| Other liabilities | 2.79M |
| Net cash provided by (used in) operating activities | -6.07M |
| Purchases of property, plant and equipment | -4.57M |
| Purchases of investments | 0 |
| Proceeds from maturities and sale of investments | 24.29M |
| Proceeds from sale of property, plant and equipment | 0 |
| Development loans | 0 |
| Increase in restricted cash | -356K |
| Net cash (used in) provided by investing activities | 19.36M |
| Principal payments under capitalized lease obligations and other debt | -308K |
| Net cash used in financing activities | -308K |
| Effect of exchange rate changes on cash and cash equivalents | -752K |
| Operating activities | 1.82M |
| Investing activities | 700K |
| Net decrease in cash and cash equivalents | 14.75M |
| Cash and cash equivalents at beginning of period | 27.77M |
| Cash and cash equivalents at end of period | 42.52M |